IL10 and neoplasm: Under hypoxia, ILC2s can transdifferentiate into an IL-10+ ILC immunosuppressive phenotype similar to that of regulatory T cells and are implicated with tumor progression in the hypoxic environments of pancreatic ductal adenocarcinoma (PDAC) [56].